|
US6187777B1
(en)
|
1998-02-06 |
2001-02-13 |
Amgen Inc. |
Compounds and methods which modulate feeding behavior and related diseases
|
|
WO2000035886A2
(en)
|
1998-12-18 |
2000-06-22 |
Axys Pharmaceuticals, Inc. |
(hetero)aryl-bicyclic heteroaryl derivatives, their preparation and their use as protease inhibitors
|
|
HRP20020349A2
(en)
|
1999-10-19 |
2004-02-29 |
Merck & Co Inc |
Tyrosine kinase inhibitors
|
|
AU2003235741B8
(en)
|
2002-01-07 |
2009-01-15 |
Eisai R&D Management Co., Ltd. |
Deazapurines and uses thereof
|
|
FR2836915B1
(fr)
|
2002-03-11 |
2008-01-11 |
Aventis Pharma Sa |
Derives d'aminoindazoles, procede de preparation et intermediaires de ce procede a titre de medicaments et compositions pharmaceutiques les renfermant
|
|
BRPI0411514A
(pt)
|
2003-06-20 |
2006-08-01 |
Coley Pharm Gmbh |
antagonistas de receptor toll-like de molécula pequena
|
|
WO2006113458A1
(en)
|
2005-04-15 |
2006-10-26 |
Bristol-Myers Squibb Company |
Heterocyclic inhibitors of protein arginine methyl transferases
|
|
RS50821B
(sr)
|
2005-06-27 |
2010-08-31 |
Sanofi-Aventis |
Derivati pirazolopiridina kao inhibitori beta-adrenergičnog receptora kinaze 1
|
|
CA2648652A1
(en)
|
2006-04-04 |
2007-10-11 |
Myriad Genetics, Inc. |
Compounds for diseases and disorders
|
|
DE102006033109A1
(de)
|
2006-07-18 |
2008-01-31 |
Grünenthal GmbH |
Substituierte Heteroaryl-Derivate
|
|
US8027888B2
(en)
|
2006-08-31 |
2011-09-27 |
Experian Interactive Innovation Center, Llc |
Online credit card prescreen systems and methods
|
|
JP2010511018A
(ja)
|
2006-12-01 |
2010-04-08 |
ガラパゴス・ナムローゼ・フェンノートシャップ |
変性疾患及び炎症性疾患の治療に有用なトリアゾロピリジン化合物
|
|
WO2008152471A1
(en)
|
2007-06-12 |
2008-12-18 |
Coley Pharmaceutical Group, Inc. |
Quinazoline derivative useful as toll-like receptor antagonist
|
|
WO2009030996A1
(en)
|
2007-09-05 |
2009-03-12 |
Coley Pharmaceutical Group, Inc. |
Triazole compounds as toll-like receptor (tlr) agonists
|
|
EP2205085A1
(en)
|
2007-09-25 |
2010-07-14 |
Merck Sharp & Dohme Corp. |
2-aryl or heteroaryl indole derivatives
|
|
WO2010036905A1
(en)
|
2008-09-26 |
2010-04-01 |
Eisai R & D Management Co., Ltd. |
Benzoxazole compounds and methods of use
|
|
US8785489B2
(en)
|
2008-10-17 |
2014-07-22 |
Boehringer Ingelheim International Gmbh |
Heteroaryl substituted indole compounds useful as MMP-13 inhibitors
|
|
TWI462920B
(zh)
|
2009-06-26 |
2014-12-01 |
葛萊伯格有限公司 |
用於治療退化性及發炎疾病之新穎化合物
|
|
JP5864417B2
(ja)
|
2009-07-16 |
2016-02-17 |
マリンクロッド エルエルシー |
トール様受容体９のアンタゴニストとしての（＋）−モルフィナンおよびその治療的使用
|
|
RU2012116207A
(ru)
|
2009-09-24 |
2013-10-27 |
Ф.Хоффманн-Ля Рош Аг |
Производные индола в качестве модуляторов crac
|
|
MX2012004792A
(es)
|
2009-10-22 |
2013-02-01 |
Vertex Pharma |
Composiciones para el tratamiento de fibrosis quistica y otras enfermedades cronicas.
|
|
DE102009058280A1
(de)
|
2009-12-14 |
2011-06-16 |
Merck Patent Gmbh |
Thiazolderivate
|
|
WO2012054862A2
(en)
|
2010-10-21 |
2012-04-26 |
The Brigham And Women's Hospital, Inc. |
Agents, compositions, and methods for treating pruritis and related skin conditions
|
|
DK2663550T3
(en)
|
2011-01-12 |
2017-03-27 |
Ventirx Pharmaceuticals Inc |
SUBSTITUTED BENZOAZEPINS AS MODULATORS OF TOLL-LIKE RECEPTORS
|
|
CN103562201B
(zh)
|
2011-01-12 |
2016-10-19 |
帆德制药股份有限公司 |
作为toll样受体调节剂的取代的苯并氮杂卓
|
|
WO2012167053A1
(en)
|
2011-06-01 |
2012-12-06 |
Janus Biotherapeutics, Inc. |
Novel immune system modulators
|
|
KR102052215B1
(ko)
|
2011-06-01 |
2019-12-04 |
야누스 바이오테라퓨틱스, 인크. |
신규한 면역 시스템 조절제
|
|
KR101913619B1
(ko)
|
2011-06-09 |
2018-12-28 |
리젠 파마슈티컬스 소시에떼 아노님 |
Gpr-119의 조절제로서의 신규한 화합물
|
|
KR101913135B1
(ko)
|
2011-07-15 |
2018-10-30 |
얀센 파마슈티칼즈, 인코포레이티드 |
감마 세크레타제 조절 인자로서의 신규의 치환 인돌 유도체
|
|
WO2013052550A2
(en)
|
2011-10-04 |
2013-04-11 |
Janus Biotherapeutics, Inc. |
Novel imidazole quinoline-based immune system modulators
|
|
TWI619704B
(zh)
|
2012-05-18 |
2018-04-01 |
大日本住友製藥股份有限公司 |
羧酸化合物
|
|
JO3407B1
(ar)
|
2012-05-31 |
2019-10-20 |
Eisai R&D Man Co Ltd |
مركبات رباعي هيدرو بيرازولو بيريميدين
|
|
US9761813B2
(en)
|
2012-08-10 |
2017-09-12 |
Doosan Corporation |
Organic light-emitting compound and organic electroluminescent device using same
|
|
EP2738172A1
(en)
|
2012-11-28 |
2014-06-04 |
Almirall, S.A. |
New bicyclic compounds as crac channel modulators
|
|
JP6223563B2
(ja)
|
2013-10-14 |
2017-11-01 |
エーザイ・アール・アンド・ディー・マネジメント株式会社 |
選択的に置換されたキノリン化合物
|
|
CN105992766A
(zh)
|
2013-12-13 |
2016-10-05 |
武田药品工业株式会社 |
作为tlr抑制剂的吡咯并[3,2-c]吡啶衍生物
|
|
HUE054672T2
(hu)
|
2014-08-15 |
2021-09-28 |
Chia Tai Tianqing Pharmaceutical Group Co Ltd |
TLR7 agonistaként alkalmazott pirrolopirimidin vegyületek
|
|
EP3398948A3
(en)
|
2014-08-22 |
2018-12-05 |
Janus Biotherapeutics, Inc. |
2,4,6,7-tetrasubstituted pteridine compounds and methods of synthesis and use thereof
|
|
MX2018014034A
(es)
|
2016-05-25 |
2019-08-29 |
Akarna Therapeutics Ltd |
Compuestos bicíclicos fusionados para el tratamiento de enfermedades.
|
|
US10071079B2
(en)
|
2016-06-29 |
2018-09-11 |
Bristol-Myers Squibb Company |
[1,2,4]triazolo[1,5-a]pyridinyl substituted indole compounds
|
|
BR112019001270A2
(pt)
|
2016-07-30 |
2019-04-30 |
Bristol-Myers Squibb Company |
compostos indol substituídos com dimetoxifenila como inibidores de tlr7, tlr8 ou tlr9
|
|
JP7028861B2
(ja)
|
2016-09-09 |
2022-03-02 |
ブリストル－マイヤーズ スクイブ カンパニー |
ピリジル置換のインドール化合物
|
|
EA202091484A1
(ru)
|
2017-12-18 |
2021-03-25 |
Бристол-Маерс Сквибб Компани |
4-азаиндольные соединения
|
|
KR102730859B1
(ko)
*
|
2017-12-20 |
2024-11-15 |
브리스톨-마이어스 스큅 컴퍼니 |
아릴 및 헤테로아릴 치환된 인돌 화합물
|
|
CN120699039A
(zh)
*
|
2019-11-04 |
2025-09-26 |
锐新医药公司 |
Ras抑制剂
|
|
MX2022005359A
(es)
*
|
2019-11-04 |
2022-06-02 |
Revolution Medicines Inc |
Inhibidores de ras.
|
|
MX2023002248A
(es)
*
|
2020-09-03 |
2023-05-16 |
Revolution Medicines Inc |
Uso de inhibidores de sos1 para tratar neoplasias malignas con mutaciones de shp2.
|
|
MX2023003060A
(es)
*
|
2020-09-15 |
2023-04-05 |
Revolution Medicines Inc |
Derivados indolicos como inhibidores de ras en el tratamiento del cancer.
|